Clinical Trial Update: Feasibility Study of Dynasplint to Prevent Trismus in Head and Neck Cancer [NA]

View source ↗

Summary

This update reports a completed feasibility study evaluating the Dynasplint device to prevent trismus in patients with head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Trismus

Drugs mentioned

• Dynasplint

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Trismus, Head and Neck Cancer | NA | Status: COMPLETED